Discontinuation report PROCYTOX TAB 25MG
| Report ID | 265250 |
| Drug Identification Number | 02241795 |
| Brand name | PROCYTOX TAB 25MG |
| Common or Proper name | Cyclophosphamide Tablets USP |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | CYCLOPHOSPHAMIDE |
| Strength(s) | 25MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 200 tablets / bottle (Prod. Code 2638B3933) |
| ATC code | L01AA |
| ATC description | ALKYLATINGAGENTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2026-05-31 |
| Actual discontinuation date | |
| Remaining supply date | |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | Please refer to customer communication dated August 13, 2025. If you have any questions regarding this communication, please do not hesitate to contact your BAXTER Pharmaceuticals Territory Manager or your BAXTER Customer Care team at 1.888.719.9955 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-08-14 | French | Compare |
| v1 | 2025-08-14 | English | Compare |
Showing 1 to 2 of 2